tiprankstipranks
American CryoStem Corporation (CRYO)
OTHER OTC:CRYO
US Market

American CryoStem (CRYO) Stock Price & Analysis

9 Followers

CRYO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.04 - $0.11
Previous Close$0.04
Volume75.50K
Average Volume (3M)100.00
Market Cap
$4.43K
Enterprise Value$943.40K
Total Cash (Recent Filing)$2.76K
Total Debt (Recent Filing)$941.73K
Price to Earnings (P/E)N/A
Beta4.95
May 14, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding44,279,279
10 Day Avg. Volume10,860
30 Day Avg. Volume100
Standard Deviation12.79
R-Squared0.00685
Alpha1.50
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)-0.01
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-4.16
Enterprise Value/Gross Profit134.44
Enterprise Value/Ebitda-0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

CRYO FAQ

What was American CryoStem Corporation’s price range in the past 12 months?
American CryoStem Corporation lowest stock price was $0.04 and its highest was $0.11 in the past 12 months.
    What is American CryoStem Corporation’s market cap?
    Currently, no data Available
    When is American CryoStem Corporation’s upcoming earnings report date?
    American CryoStem Corporation’s upcoming earnings report date is May 14, 2018 which is 2176 days ago.
      How were American CryoStem Corporation’s earnings last quarter?
      Currently, no data Available
      Is American CryoStem Corporation overvalued?
      According to Wall Street analysts American CryoStem Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does American CryoStem Corporation pay dividends?
        American CryoStem Corporation does not currently pay dividends.
        What is American CryoStem Corporation’s EPS estimate?
        American CryoStem Corporation’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does American CryoStem Corporation have?
        American CryoStem Corporation has 44,279,278 shares outstanding.
          What happened to American CryoStem Corporation’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of American CryoStem Corporation?
          Currently, no hedge funds are holding shares in CRYO
          ---

          American CryoStem Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          American CryoStem Corporation

          American CryoStem Corp. is engaged in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells; and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski on November 18, 2008 and is headquartered in Eatontown, NJ.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Repligen
          Compugen
          Mesoblast
          Predictive Technology Group
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis